0.5299
price down icon0.36%   -0.0005
 
loading
Schlusskurs vom Vortag:
$0.5294
Offen:
$0.5146
24-Stunden-Volumen:
200.61K
Relative Volume:
0.21
Marktkapitalisierung:
$31.53M
Einnahmen:
$2.06M
Nettoeinkommen (Verlust:
$-19.80M
KGV:
-0.7357
EPS:
-0.7203
Netto-Cashflow:
$-20.12M
1W Leistung:
-6.57%
1M Leistung:
-2.31%
6M Leistung:
+43.26%
1J Leistung:
-65.07%
1-Tages-Spanne:
Value
$0.5141
$0.5389
1-Wochen-Bereich:
Value
$0.4838
$0.5912
52-Wochen-Spanne:
Value
$0.3067
$1.7599

Femasys Inc Stock (FEMY) Company Profile

Name
Firmenname
Femasys Inc
Name
Telefon
770-500-3910
Name
Adresse
3950 JOHNS CREEK COURT, SUWANEE
Name
Mitarbeiter
71
Name
Twitter
Name
Nächster Verdiensttermin
2025-08-08
Name
Neueste SEC-Einreichungen
Name
FEMY's Discussions on Twitter

Compare FEMY vs ISRG, BDX, ALC, RMD, MDLN

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Instruments & Supplies icon
FEMY
Femasys Inc
0.5299 31.50M 2.06M -19.80M -20.12M -0.7203
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
504.75 176.65B 10.06B 2.88B 2.49B 7.876
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
171.24 49.56B 21.92B 1.76B 2.63B 6.1223
Medical Instruments & Supplies icon
ALC
Alcon Inc
83.73 40.50B 10.19B 1.05B 1.38B 2.1044
Medical Instruments & Supplies icon
RMD
Resmed Inc
258.47 37.63B 5.40B 1.49B 1.78B 10.12
Medical Instruments & Supplies icon
MDLN
Medline Inc
43.31 36.02B 28.43B 1.16B 1.26B 1.4457

Femasys Inc Stock (FEMY) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-11-20 Eingeleitet Laidlaw Buy

Femasys Inc Aktie (FEMY) Neueste Nachrichten

pulisher
Mar 03, 2026

Lake Street initiates Femasys stock coverage with buy rating - Investing.com

Mar 03, 2026
pulisher
Mar 01, 2026

FEMY Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 01, 2026
pulisher
Feb 28, 2026

FEMY Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Feb 28, 2026
pulisher
Feb 28, 2026

FEMY Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Feb 28, 2026
pulisher
Feb 27, 2026

Femasys Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Feb 27, 2026
pulisher
Feb 27, 2026

Femasys’s FemBloc Pivotal Trial Update: What Investors Should Watch in Women’s Health - TipRanks

Feb 27, 2026
pulisher
Feb 26, 2026

Femasys Announces FemBloc® Permanent Birth Control Has - GlobeNewswire

Feb 26, 2026
pulisher
Feb 25, 2026

Femasys Announces FemBloc Permanent Birth Control Has Achieved MDSAP Certification, Advancing Global Market Access - Bitget

Feb 25, 2026
pulisher
Feb 24, 2026

Sentiment Watch: Is Femasys Inc stock undervalued right nowJuly 2025 Setups & Low Risk Investment Opportunities - baoquankhu1.vn

Feb 24, 2026
pulisher
Feb 24, 2026

Femasys receives CPT code approval for infertility treatment By Investing.com - Investing.com India

Feb 24, 2026
pulisher
Feb 23, 2026

FEMY SEC FilingsFEMASYS INC 10-K, 10-Q, 8-K Forms - Stock Titan

Feb 23, 2026
pulisher
Feb 23, 2026

Trend Review: Can Femasys Inc benefit from deglobalization2025 Big Picture & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn

Feb 23, 2026
pulisher
Feb 23, 2026

Femasys receives CPT code approval for infertility treatment - Investing.com UK

Feb 23, 2026
pulisher
Feb 23, 2026

AMA procedure code supports new infertility option for over 10M US women - Stock Titan

Feb 23, 2026
pulisher
Feb 22, 2026

Femasys Receives AMA CPT Editorial Panel Approval for New Category III CPT Code for FemaSeed Intratubal Insemination - Bitget

Feb 22, 2026
pulisher
Feb 20, 2026

Femasys (FEMY) CEO awarded 729,000 RSUs vesting through 2027 - Stock Titan

Feb 20, 2026
pulisher
Feb 20, 2026

Femasys (NASDAQ: FEMY) CFO receives 342,000 restricted stock units - Stock Titan

Feb 20, 2026
pulisher
Feb 17, 2026

Femasys (FEMY) CTO reports common stock and option holdings in Form 3 - Stock Titan

Feb 17, 2026
pulisher
Feb 14, 2026

How cyclical is Femasys Inc.’s revenue streamJuly 2025 News Drivers & Technical Pattern Based Buy Signals - mfd.ru

Feb 14, 2026
pulisher
Feb 13, 2026

Femasys : Shareholder Update – 2025 in Review - marketscreener.com

Feb 13, 2026
pulisher
Feb 11, 2026

Can Femasys Inc. sustain its profitabilityJuly 2025 Weekly Recap & Risk Managed Investment Strategies - mfd.ru

Feb 11, 2026
pulisher
Feb 09, 2026

Forecast Cut: What dividend growth rate does Femasys Inc offerMarket Risk Summary & Safe Investment Capital Preservation Plans - baoquankhu1.vn

Feb 09, 2026
pulisher
Feb 04, 2026

Femasys stock rises on new distribution partnership in Switzerland By Investing.com - Investing.com Australia

Feb 04, 2026
pulisher
Feb 03, 2026

Femasys expands European presence with Swiss distribution deal By Investing.com - Investing.com Nigeria

Feb 03, 2026
pulisher
Feb 03, 2026

Femasys Inc. Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products - marketscreener.com

Feb 03, 2026
pulisher
Feb 03, 2026

Femasys stock rises on new distribution partnership in Switzerland - Investing.com

Feb 03, 2026
pulisher
Feb 03, 2026

Femasys expands European presence with Swiss distribution deal - Investing.com

Feb 03, 2026
pulisher
Feb 03, 2026

Femasys Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products - The Manila Times

Feb 03, 2026
pulisher
Feb 03, 2026

Femasys Inc. Expands European Presence with New Distribution Partnership in Switzerland - Quiver Quantitative

Feb 03, 2026
pulisher
Feb 01, 2026

Insider Sell: Is Omega Healthcare Investors Inc subject to activist investor interest2025 Major Catalysts & Smart Investment Allocation Tips - baoquankhu1.vn

Feb 01, 2026
pulisher
Feb 01, 2026

Trading Action: Can Femasys Inc sustain its profitabilityTake Profit & Accurate Entry/Exit Alerts - baoquankhu1.vn

Feb 01, 2026
pulisher
Jan 31, 2026

Femasys Secures Major Order for FemBloc Launch - MSN

Jan 31, 2026
pulisher
Jan 20, 2026

Travel Stocks: What is PCARs revenue forecastEarnings Trend Report & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn

Jan 20, 2026
pulisher
Jan 16, 2026

Returns Recap: Does Ares Management Corporation meet Warren Buffetts criteria2025 Earnings Impact & Growth Oriented Trading Recommendations - baoquankhu1.vn

Jan 16, 2026
pulisher
Jan 16, 2026

Femasys Receives Nasdaq Extension to Regain Listing Compliance - The Globe and Mail

Jan 16, 2026
pulisher
Jan 15, 2026

Femasys granted 180-day extension by Nasdaq to meet minimum bid price rule - Investing.com

Jan 15, 2026
pulisher
Jan 15, 2026

Femasys Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Jan 15, 2026
pulisher
Jan 15, 2026

Stock Recap: Will FUFU benefit from geopolitical trendsCPI Data & Fast Entry Momentum Trade Alerts - baoquankhu1.vn

Jan 15, 2026
pulisher
Jan 15, 2026

Femasys Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement - Sahm

Jan 15, 2026
pulisher
Jan 14, 2026

Femasys receives 180-day Nasdaq extension to meet minimum bid price - Investing.com Nigeria

Jan 14, 2026
pulisher
Jan 14, 2026

Femasys secures Nasdaq extension to regain bid price compliance - MSN

Jan 14, 2026
pulisher
Jan 14, 2026

Femasys Granted 180-Day Extension By Nasdaq To Regain Compliance With Minimum Bid Price Requirement - TradingView

Jan 14, 2026
pulisher
Jan 14, 2026

Nasdaq gives Femasys more time to fix sub-$1 share price by July 2026 - Stock Titan

Jan 14, 2026
pulisher
Jan 14, 2026

Femasys partners with Refuah Health Center to expand FemaSeed fertility treatment - Investing.com Nigeria

Jan 14, 2026
pulisher
Jan 13, 2026

Dow Update: Why Femasys Inc stock attracts global investorsTrade Volume Summary & AI Forecast Swing Trade Picks - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 13, 2026

Femasys partners with Refuah Health Center to expand FemaSeed fertility treatment By Investing.com - Investing.com South Africa

Jan 13, 2026
pulisher
Jan 13, 2026

Femasys Inc. Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed®? in Community-Based Care - marketscreener.com

Jan 13, 2026

Finanzdaten der Femasys Inc-Aktie (FEMY)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$71.71
price up icon 1.26%
$182.71
price up icon 0.04%
medical_instruments_supplies COO
$81.49
price down icon 2.25%
$75.41
price down icon 0.07%
medical_instruments_supplies WST
$248.41
price down icon 1.08%
$43.45
price down icon 1.16%
Kapitalisierung:     |  Volumen (24h):